Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 23 of about 9 companies and 14 funds for Gene Douglas�
Company Exchange Symbol Last price Quote change Market cap
Qiagen NV NASDAQ QGEN 23.57 -0.14 (-0.59%) 5.65B
QIAGEN NV, (QIAGEN) is a holding company, which provides sample and assay technologies. The consumable products such as sample and assay kits and automated ...
GenVec Inc NASDAQ GNVC 2.20 +0.25 (12.82%) 37.99M
GenVec, Inc. develops gene-based pharmaceuticals and therapies for the treatment of major medical needs. The Company combines its patented gene transfer ...
Precision Drilling Corp (USA) NYSE PDS 6.84 +0.60 (9.62%) 1.99B
Precision Drilling Corporation (Precision) is a provider of contract drilling and completion and production services primarily to oil and natural gas ...
Executive:
Gene C. Stahl
Precision Drilling Corporation TSE PD 7.91 +0.68 (9.41%) 2.21B
Precision Drilling Corporation (Precision) is a provider of contract drilling and completion and production services primarily to oil and natural gas ...
Executive:
Gene C. Stahl
Applied Micro Circuits Corporation NASDAQ AMCC 6.54 +0.13 (2.03%) 514.90M
The Company's products include the X-Gene ARM 64 bit Server on a Chip solution, along with the X-WeaveTM family of connectivity products, ...
Qiagen NV ETR QIA 19.20 +0.20 (1.03%) 4.67B
QIAGEN NV, (QIAGEN) is a holding company, which provides sample and assay technologies. The consumable products such as sample and assay kits and automated ...
Qiagen NV FRA QIA 19.09 +0.25 (1.33%) 4.69B
QIAGEN NV, (QIAGEN) is a holding company, which provides sample and assay technologies. The consumable products such as sample and assay kits and automated ...
Assurant, Inc. NYSE AIZ 68.65 +0.94 (1.39%) 4.82B
Assurant, Inc. (Assurant) is a provider of specialized insurance products and related services in North America and select worldwide markets.
Executive:
Gene E. Mergelmeyer
Critical Outcome Technologies Inc. CVE COT 0.235 -0.010 (-4.08%) 27.33M
Critical Outcome Technologies Inc. (COTI) is a biotechnology company focused on applying its computer-based technology, CHEMSAS, to identify, profile, ...
Executive:
Gene Kelly
Mutual Fund Symbol Nav Nav change
American Beacon Small Cap Value Fund Class Institutional AVFIX 28.10 +0.09 (0.32%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Investor Class AVPAX 27.23 +0.08 (0.29%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Investor Class AAEPX 11.07 +0.03 (0.27%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Class AMR AAMRX 11.38 +0.03 (0.26%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Class A AEMAX 11.07 +0.02 (0.18%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Advisor Class AASSX 26.96 +0.08 (0.30%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Class Y ABSYX 27.81 +0.08 (0.29%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Class A ABSAX 26.90 +0.09 (0.34%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Class AMR AASVX 28.05 +0.09 (0.32%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Class Institutional AEMFX 11.28 +0.03 (0.27%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund C Class AEMCX 10.95 +0.03 (0.27%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Class Y ACEYX 11.33 +0.03 (0.27%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Class R ASCVX 26.44 +0.08 (0.30%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund C Class ASVCX 26.28 +0.07 (0.27%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.